About Acceleron Pharma

About

Our Company

Acceleron is dedicated to the discovery and development of innovative, life-changing medicines for patients with a wide range of serious and rare diseases. Our research focuses on harnessing the power of the TGF-beta protein superfamily, the target-rich area of biology behind the body’s remarkable capacity for cellular growth and repair. Our approach to drug discovery is driven by deep scientific expertise—and an urgency to deliver effective treatments to thousands of patients who have few or no therapeutic options. The Company’s lead product candidate, luspatercept, is being evaluated in two Phase 3 studies in a global partnership with Celgene to treat chronic, sometimes debilitating anemias in myelodysplastic syndromes (MDS) and beta-thalassemia. We are also advancing clinical programs in neuromuscular disorders and cancer, and preclinical research in fibrotic and other diseases.

Our mission is to build a portfolio of innovative medicines that transform patients' lives by leveraging our research and expertise in the TGF-beta superfamily

Work with urgency to discover and develop drugs that address the serious unmet medical needs of patients

Our Core Values

  • Work with urgency to discover and develop drugs that address the serious unmet medical needs of patients
Provide an inclusive, respectful and team-based work environment
  • Build partnerships with patients, physicians, industry, payors and regulators to optimize the value of our therapeutics to all of our stakeholders
  • Provide an inclusive, respectful and team-based work environment
Pharma Careers
  • Build and maintain a culture in which employees are…
    • Guided by integrity and respect
    • Driven by passion and courage
    • Committed to developing people and building great teams
    • Motivated to innovate, challenged to exceed expectations, and rewarded for success